Chapter 1. Preface
1.1 Report Description and Scope
1.2 Research Scope
1.3 Research Methodology
1.3.1 Market Research Type
1.3.2 Market Research Methodology
Chapter 2. Executive Summary
2.1 Global Nucleic Acid Testing Market, (2026 - 2035) (USD Billion)
2.2 Global Nucleic Acid Testing Market: Snapshot
Chapter 3. Global Nucleic Acid Testing Market - Industry Analysis
3.1 Nucleic Acid Testing Market: Market Dynamics
3.2 Market Drivers
3.2.1 The market is propelled by the rising burden of infectious and genetic diseases, the rapid adoption of Point-of-Care (POC) molecular diagnostics, and the integration of AI-driven high-throughput screening for personalized oncology.
3.3 Market Restraints
3.3.1 Expansion is limited by high capital costs for advanced PCR and NGS platforms, stringent and evolving regulatory hurdles (like IVDR), and a critical shortage of skilled molecular biologists in emerging economies.
3.4 Market Opportunities
3.4.1 Significant potential exists in the development of isothermal amplification (INAAT) for low-resource settings, the surge in liquid biopsy for early cancer detection, and the expansion of genomic surveillance programs for pandemic preparedness.
3.5 Market Challenges
3.5.1 Key hurdles include mitigating assay sensitivity risks against viral mutations, managing complex data privacy and bioethics in genomic testing, and ensuring supply chain resilience for critical enzymes and reagents during global health crises.
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Technology
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-Use
Chapter 4. Global Nucleic Acid Testing Market- Competitive Landscape
4.1 Company Market Share Analysis
4.1.1 Global Nucleic Acid Testing Market: Company Market Share, 2025
4.2 Strategic Development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, collaborations, and joint ventures
4.2.4 Research and development and regional expansion
4.3 Price Trend Analysis
Chapter 5. Global Nucleic Acid Testing Market - Technology Analysis
5.1 Global Nucleic Acid Testing Market Overview: Technology
5.1.1 Global Nucleic Acid Testing Market share, By Technology, 2025 and 2035
5.2 PCR Tests
5.2.1 Global Nucleic Acid Testing Market by PCR Tests, 2026 - 2035 (USD Billion)
5.3 Isothermal Amplification
5.3.1 Global Nucleic Acid Testing Market by Isothermal Amplification, 2026 - 2035 (USD Billion)
5.4 Others
5.4.1 Global Nucleic Acid Testing Market by Others, 2026 - 2035 (USD Billion)
Chapter 6. Global Nucleic Acid Testing Market - Application Analysis
6.1 Global Nucleic Acid Testing Market Overview: Application
6.1.1 Global Nucleic Acid Testing Market Share, By Application, 2025 and 2035
6.2 Infectious Diseases
6.2.1 Global Nucleic Acid Testing Market by Infectious Diseases, 2026 - 2035 (USD Billion)
6.3 Oncology
6.3.1 Global Nucleic Acid Testing Market by Oncology, 2026 - 2035 (USD Billion)
6.4 Genetic Testing
6.4.1 Global Nucleic Acid Testing Market by Genetic Testing, 2026 - 2035 (USD Billion)
6.5 Others
6.5.1 Global Nucleic Acid Testing Market by Others, 2026 - 2035 (USD Billion)
Chapter 7. Global Nucleic Acid Testing Market - End-Use Analysis
7.1 Global Nucleic Acid Testing Market Overview: End-Use
7.1.1 Global Nucleic Acid Testing Market Share, By End-Use, 2025 and 2035
7.2 Hospitals & Clinics
7.2.1 Global Nucleic Acid Testing Market by Hospitals & Clinics, 2026 - 2035 (USD Billion)
7.3 Diagnostic Laboratories
7.3.1 Global Nucleic Acid Testing Market by Diagnostic Laboratories, 2026 - 2035 (USD Billion)
7.4 Research Institutions
7.4.1 Global Nucleic Acid Testing Market by Research Institutions, 2026 - 2035 (USD Billion)
Chapter 8. Nucleic Acid Testing Market - Regional Analysis
8.1 Global Nucleic Acid Testing Market Regional Overview
8.2 Global Nucleic Acid Testing Market Share, by Region, 2025 & 2035 (USD Billion)
8.3 North America
8.3.1 North America Nucleic Acid Testing Market, 2026 - 2035 (USD Billion)
8.3.1.1 North America Nucleic Acid Testing Market, by Country, 2026 - 2035 (USD Billion)
8.3.2 North America Nucleic Acid Testing Market, by Technology, 2026 - 2035
8.3.2.1 North America Nucleic Acid Testing Market, by Technology, 2026 - 2035 (USD Billion)
8.3.3 North America Nucleic Acid Testing Market, by Application, 2026 - 2035
8.3.3.1 North America Nucleic Acid Testing Market, by Application, 2026 - 2035 (USD Billion)
8.3.4 North America Nucleic Acid Testing Market, by End-Use, 2026 - 2035
8.3.4.1 North America Nucleic Acid Testing Market, by End-Use, 2026 - 2035 (USD Billion)
8.4 Europe
8.4.1 Europe Nucleic Acid Testing Market, 2026 - 2035 (USD Billion)
8.4.1.1 Europe Nucleic Acid Testing Market, by Country, 2026 - 2035 (USD Billion)
8.4.2 Europe Nucleic Acid Testing Market, by Technology, 2026 - 2035
8.4.2.1 Europe Nucleic Acid Testing Market, by Technology, 2026 - 2035 (USD Billion)
8.4.3 Europe Nucleic Acid Testing Market, by Application, 2026 - 2035
8.4.3.1 Europe Nucleic Acid Testing Market, by Application, 2026 - 2035 (USD Billion)
8.4.4 Europe Nucleic Acid Testing Market, by End-Use, 2026 - 2035
8.4.4.1 Europe Nucleic Acid Testing Market, by End-Use, 2026 - 2035 (USD Billion)
8.5 Asia Pacific
8.5.1 Asia Pacific Nucleic Acid Testing Market, 2026 - 2035 (USD Billion)
8.5.1.1 Asia Pacific Nucleic Acid Testing Market, by Country, 2026 - 2035 (USD Billion)
8.5.2 Asia Pacific Nucleic Acid Testing Market, by Technology, 2026 - 2035
8.5.2.1 Asia Pacific Nucleic Acid Testing Market, by Technology, 2026 - 2035 (USD Billion)
8.5.3 Asia Pacific Nucleic Acid Testing Market, by Application, 2026 - 2035
8.5.3.1 Asia Pacific Nucleic Acid Testing Market, by Application, 2026 - 2035 (USD Billion)
8.5.4 Asia Pacific Nucleic Acid Testing Market, by End-Use, 2026 - 2035
8.5.4.1 Asia Pacific Nucleic Acid Testing Market, by End-Use, 2026 - 2035 (USD Billion)
8.6 Latin America
8.6.1 Latin America Nucleic Acid Testing Market, 2026 - 2035 (USD Billion)
8.6.1.1 Latin America Nucleic Acid Testing Market, by Country, 2026 - 2035 (USD Billion)
8.6.2 Latin America Nucleic Acid Testing Market, by Technology, 2026 - 2035
8.6.2.1 Latin America Nucleic Acid Testing Market, by Technology, 2026 - 2035 (USD Billion)
8.6.3 Latin America Nucleic Acid Testing Market, by Application, 2026 - 2035
8.6.3.1 Latin America Nucleic Acid Testing Market, by Application, 2026 - 2035 (USD Billion)
8.6.4 Latin America Nucleic Acid Testing Market, by End-Use, 2026 - 2035
8.6.4.1 Latin America Nucleic Acid Testing Market, by End-Use, 2026 - 2035 (USD Billion)
8.7 The Middle-East and Africa
8.7.1 The Middle-East and Africa Nucleic Acid Testing Market, 2026 - 2035 (USD Billion)
8.7.1.1 The Middle-East and Africa Nucleic Acid Testing Market, by Country, 2026 - 2035 (USD Billion)
8.7.2 The Middle-East and Africa Nucleic Acid Testing Market, by Technology, 2026 - 2035
8.7.2.1 The Middle-East and Africa Nucleic Acid Testing Market, by Technology, 2026 - 2035 (USD Billion)
8.7.3 The Middle-East and Africa Nucleic Acid Testing Market, by Application, 2026 - 2035
8.7.3.1 The Middle-East and Africa Nucleic Acid Testing Market, by Application, 2026 - 2035 (USD Billion)
8.7.4 The Middle-East and Africa Nucleic Acid Testing Market, by End-Use, 2026 - 2035
8.7.4.1 The Middle-East and Africa Nucleic Acid Testing Market, by End-Use, 2026 - 2035 (USD Billion)
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Roche Diagnostics
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 Qiagen
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Bio-Rad Laboratories
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 Illumina
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments
9.7 PerkinElmer
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Business Strategy
9.7.5 Recent Developments
Frequently Asked Questions
Nucleic acid testing is a diagnostic method detecting genetic material from pathogens or cells for disease identification, using amplification techniques like PCR for high sensitivity.
Key factors include infectious disease prevalence, molecular tech advancements, AI integrations, and regulatory approvals for POC devices.
The nucleic acid testing market is projected to grow from approximately USD 11.9 billion in 2026 to USD 27.65 billion by 2035.
The CAGR for the nucleic acid testing market during 2026-2035 is expected to be around 9.3%, driven by diagnostics demands.
North America will contribute notably, accounting for over 40% of the market value, led by advancements in the United States.
Major players include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Qiagen, Bio-Rad Laboratories, Illumina, and PerkinElmer.
The global nucleic acid testing market report provides insights into size, segmentation, dynamics, regional analysis, players, trends, and forecasts.
The value chain includes reagent sourcing, kit manufacturing, instrument assembly, distribution, and end-user testing services.
Market trends are evolving toward POC and multiplex testing, with preferences shifting to rapid, accurate diagnostics for personalized care.
Regulatory factors include FDA approvals for assays, while environmental factors involve sustainable lab practices, driving innovations but increasing costs.